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Ethnopharmacological relevance: Helicteres sacarolha, popularly known in Brazil as ‘rosquinha’,
‘sacarolhas’, ‘semente-de-macaco’, is widely distributed in different phytogeographic zones in Brazil.
Preparations from its roots and leaves are employed in popular Brazilian medicine in the treatments of
ailments such as peptic ulcer, hypertension among others. Cytotoxicity, acute oral and subchronic toxicity
of the hydroethanolic extract of Helicteres sacrolha was investigated as well as the classes of
phytochemical present in the extract.
Materials and methods: Hydroethanolic (70%) extract of Helicteres sacarolha (HEHs) was prepared by
maceration. Potential cytotoxicity was evaluated in CHO-k1 cells. Acute administration of HEHs was done
in mice as a single dose up to 5000 mg/kg and subchronic oral toxicity study for 30 days in Wistar rats at
daily oral doses of 0, 250 and 750 mg/kg b.w. Clinical observations and toxicological related parameters
were determined every 6 days. Blood was collected for biochemical and hematological analyses, while
histological examinations were performed on selected organs. Selected secondary metabolites detected
were quantiﬁed by UV-spectrophotometry and high performance liquid chromatography (HPLC).
Results: The extract was non-cytotoxic to CHO-k1 cells. In acute oral toxicity, there was no mortality or
clinical alterations in the female mice, at all doses, except for the transient diarrhea observed at 5000 mg/
kg acute. Doses up to 2000 mg/kg caused no mortality or treatment-related clinical manifestations in the
male mice, but treatment-related alterations were however observed at 4000 mg/kg, with mortalities
recorded at 5000 mg/kg. During the subchronic oral toxicity study, no mortality or treatment-related
clinical signs were observed. Differences in relative organ weight, hematological parameters and
histopathology observations between the treated and the control groups were considered not to be
treatment-related. Spectrophotometric analysis revealed the presence of relatively high content of
phenolics and ﬂavonoids in HEHs. HPLC analysis conﬁrmed the presence of the quantiﬁed compounds
and demonstrated the presence of ellagic acid, morin and naringin.
Conclusion: Our results conﬁrmed that HEHs have a broad safety margin for therapeutic use.
& 2014 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Helicteres sacarolha A. St.- Hil. et al., a Malvaceae, belongs to the
pantropical genus Helicteres that is comprised of approximately
60 species, native to the tropics of both hemispheres (Goldberg,
2009). Members of the genus Helicteres are most abundant in
Americas in which 38 species are distributed from Mexico, Central
America, the Caribbean and South America through North Western
Argentina and slightly South of the tropics line in Eastern Para-
guay, Brazil. The genus members are also found in the old world,
Southeast Asia and Australia (Goldberg, 2009). The members of
the genus are shrubs or small trees of dry lowland areas. They are
characterized by having distinctive fruits, which are spiral cap-
sules, many seeded and with a long androgynophore in free or
fused form.
Helicteres sacarolha is widely distributed in Brazil and Bolivia
(Cristóbal, 2001). It is non endemic, native plant present in the
phytogeographic areas of the Amazon, Cerrado and Atlantic Forest.
Its distribution spreads over the North, Northeast, Midwest and
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Southeast regions of Brazil (Cristóbal, 2001; Franceschinelli and
Bawa, 2005). It is a shrub up to 1.5 m tall, branched from the base
or erects ﬁne braches. The fruits are small capsules (2–3 cm in
length) with 10–30 seeds. The plant possesses xylopodes, which
re-sprout in the beginning of the raining season (Franceschinelli
and Bawa, 2005). It is popularly known in Brazil as ‘semente-de-
macaco’, ‘saca-rolhas’, ‘rosquinha’ or ‘rosquinha-de-gato’ because
of its fruits shape. Populations of Helicteres sacarolha are usually
found growing in clumps.
Preparations from its root and leaves are used in Brazilian
popular medicine in the lowering of hypertension, alleviation of
gastric ulcer symptoms, syphilis, tooth eruption, liver problems,
inﬂammation of the ovaries, amenorrhea and in blood depuration
(Truiti et al., 2005; Borba and Macedo, 2006; Silva et al., 2010;
Bieski et al., 2012).
In Brazilian popular medicine, about 10 g of the dry leaves is
soaked in 1 l of water to make an infusion. In the treatment of
gastric ulcer, a cup (150 mL) of the resulting solution is taken twice
a day for 20–30 days. There is no report of toxicity by the local
population that uses the plant as medicine (Bieski et al., 2012).
Despite the use of this plant in folk medicine by several
traditional communities, there have been no reports on the
toxicological or phytochemical investigation of this species until
now to the best of our knowledge. The present work is aimed at
evaluating the potential toxicity of Helicteres sacarolha using
in vitro and in vivo models of acute and sub-chronic toxicities, in
addition to its phytochemical analysis.
2. Materials and methods
2.1. Experimental animals and housing conditions
Albino mice Mus musculus, Swiss-Webster strain (25–30 g) and
albino rats Rattus norvegicus, Wistar strain (180–200 g) were used
in the in vivo studies. Animals were provided by the Central
Animal House of the Federal University Mato Grosso (UFMT).
The animals were kept in a room where the temperature was
maintained at 2273 1C under a 12 h light–dark cycle. They were
provided with standard laboratory chow (Purina, Labinas, Goiás,
Brazil) and water ad libitum. The protocol for this study was
according to the ethical principles of animal experimentation
and was approved by the UFMT Ethics Committee for Animal
Use under no. 23108.060195/13-5.
2.2. Plant material
2.2.1. Plant collection
The leaves of Helicteres sacarolha were collected from the Bahia
do Campo Community Poconé municipal, located in Mato Grosso
State, Brazil in the month of March 2013. Three ﬂowered voucher
specimens were herborized and were identiﬁed at Herbarium of
the Federal University of Mato Grosso (UFMT), Brazil. The same
was deposited in the collection of the Herbarium with register no.
40.722. The plant name was checked with www.theplantlist.org,
on the 14th of August 2014. The plant collection was done based
on an earlier ethnopharmacological study (Bieski et al., 2012). In
order to access the traditional knowledge associated with genetic
resources for research purposes from the traditional communities,
an ethical clearance (approval no. 247) from the Brazilian Ministry
of Environment, under the auspices of the Council for Genetic
Heritage Management (CGEN/MMA), was obtained.
2.2.2. Plant extract preparation
Ten kilograms (10 kg) of the fresh leaves of Helicteres sacarolha
were cleaned and dried in the oven (model TE-394/4 Tecnal,
Brazil) at 4071 1C, for a period of 72 h, milled using an electric
miller (model TE-625 Tecnal, Brazil) and thereafter sieved (mesh
size No. 40). The powdered plant material was extracted by
maceration in 70% hydroethanolic solution (1:10 w/v) for 7 days
in order to obtain the aqueous ethanolic extract. After extraction,
the solvent was partially evaporated under reduced pressure
(600 mmHg) at 40 1C in a rotary evaporator (model 801, Fisatom,
Brazil), and residual solvent was eliminated in a hot air circulating
oven (model TE-394/4 Tecnal, Brazil) at 4071 1C. The extract was
then lyophilized (Lyophilizer model LL 1500, Heto, Italy) to obtain
HEHs, which was bottled and kept in a fridge (model 350 L,
Brastemp, Brazil) at 471 1C. The extract yield per gram of dried
powdered leaves was 10%. HEHs was dissolved in distilled water at
the time of use.
2.3. Quantitative analysis of selected phytochemical constituents
2.3.1. Quantiﬁcation of total phenolics content
Quantiﬁcation of the total phenols was performed by the Folin–
Ciocalteu method as described by Amorim et al. (2008) using
tannic acid as a standard. Total phenols were determined by
interpolation of the absorbance of the samples against a calibra-
tion curve constructed with different concentrations of tannic acid
standard and expressed as mg tannic acid equivalents (TAE) per
gram of lyophilized extract (TAE mg/g). All experiments were
performed in triplicate.
2.3.2. Quantiﬁcation of total ﬂavonoid content
The quantiﬁcation of total ﬂavonoids was performed accord-
ingly as previously described (Peixoto-Sobrinho et al., 2008) with
slight modiﬁcations and using rutin as standard. The total ﬂavo-
noid contents were determined using a calibration curve con-
structed with different concentrations of rutin standard and
expressed as milligrams of rutin equivalents (RE) per gram of
lyophilized extract (mg RE/g).
2.4. HPLC analysis
The HPLC system (Shimadzu, Tokyo, Japan) consisted of a
chromatograph (LC-10 Avp series ) equiped with a pump (LC-10
AD), a degasser (DGU-14A) to pump the mobile phase, rheodyne
manual injector (20 μL loop) and class integrator (LC-10A), a
UV–vis (SPD-10A) detector and a column oven (CTO 10A). The
extract solutions and standards were prepared with methanol and
ﬁltered through a Millipores (0.45 mM pore size) membrane. The
separation was carried out by a gradient system, using a reverse-
phase Phenomenex Luna 5 mm C18 (2) (2504.6 mm2) column
with direct-connect C18 Phenomenex Security Guard Cartridges
(43.0 mm2) ﬁlled with similar material as the main column.
Mobile phase A was 0.2% formic acid in Milli-Q water and mobile
phase B was 0.2% formic acid in methanol. Program gradient:
0–0.01 min, 5% B; 0.01–5 min, 25% B, 5–10 min, 45% B, 10–16 min
45% B, 16–20 min, 80% B, 20–25 min 80% B, 25–30 min 80% B, 30–
35 min, 100% B; 35–35.1 min, 100% B. Flow rate: 1 mL/min,
temperature: 35 1C. UV detectionwas done at 280 nm and 340 nm.
The compounds were identiﬁed by comparing the retention
times of samples with the authentic standards, such as naringin,
rutin, ellagic acid, myricetin, morin, quercetin, (7)-naringenin
and luteolin (Sigmas). Concentrations of the compounds were
expressed in micrograms per milligram of extract (μg/mg) by
correlating the area of the analyte with the calibration curve of
standards built in concentrations of 125–1000 μg/mL.
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2.5. Toxicological evaluation
2.5.1. Cytotoxicity evaluation
Potential cytotoxicity of HEHs was evaluated following a
described method (Nakayama et al., 1997). Brieﬂy, CHO-k1 cells
were exposed to different concentrations (3.12–200 μg/mL) of
HEHs for up to 72 h. Thereafter, the cells were washed and the
cell viability was assessed by using Alamar Blue. Aliquots of 200 μL
of stock Alamar Blue solution were added to each well (containing
200 μL of medium [10% ﬁnal solution]) and incubated for 5 h. The
absorbance at 540 nm and 620 nm was read on a plate reader.
Doxorubicin (Sigma) was used as a positive control.
2.5.2. Acute toxicity screening test
The effect of HEHs on the general behavior of conscious animals
was evaluated in mice, as previously described (Malone and
Robichaud, 1962) with slight modiﬁcation. Brieﬂy, male and female
mice (n¼5/group) received by gavage (p.o.) the HEHs at doses
of 500, 1000, 2000, 4000 and 5000 mg/kg body weight (b.w.). One
control animal per group, received the vehicle (distilled water,
10 mL/kg). Animals were observed individually in open ﬁeld at
5, 10, 15, 30, 60, 120 and 240 min and once a day, for a period of 14
days, noting any clinical signs or mortality, according to established
criteria (Malone and Robichaud, 1962).
2.5.3. Subchronic toxicity studies
Subchronic toxicity was evaluated as previously proposed
(Chan et al., 1982). Animals (n¼6/group), kept in metabolic cages
(Ugo Basile, model 41800, Italy), were treated daily by oral gavage
with the vehicle (distilled water, 0.01 mL/g) and HEHs (250 and
750 mg/kg b.w.) for 30 days. In order to keep constant the doses
administered, adjustments in dosage were made based on an
animal's body weight gain every 3 days. Body weight and intake
of food and water were determined every 3 days and grouped
every 6 days (D1, D2, D3, D4 and D5) over the 30-day period. Signs
and symptoms of behavioral alterations were recorded, including
skin, eyes, gastrointestinal, respiratory, central nervous system and
peripheral alterations, including any other general changes. At the
end of the treatments, animals were anesthetized with intraper-
itoneal injection of pentobarbital sodium at a dose of 50 mg/kg on
the 30th day after a 12 h overnight fasting. Blood was collected via
vena cava for biochemical and hematological analyses. Animals
were then sacriﬁced by cervical dislocation and the organs (liver,
heart, lung, kidneys, stomach and spleen) were removed. The
relative weights were calculated (weight of the organ/body
weight100) and subjected to a complete necropsy, including
external body macroscopic examinations. The organs were ﬁxed in
10% formalin solution for histopathological analysis.
2.5.4. Hematological analysis
Blood samples were collected in Vacutainers tubes containing
EDTA and hematological tests, which included hematocrit (Ht),
hemoglobin (Hb), total platelets, erythrocytes, total leukocytes,
neutrophils, lymphocytes, monocytes, eosinophils, and basophils
were performed with an automatic cell counter (Cell Dyn 3700,
Abott Laboratories, Minnesota, USA).
2.5.5. Biochemical analysis
For biochemical analysis, blood, without additive, was centri-
fuged at 3000 g for 10 min at 4 1C. Serum was separated and
stored at 20 1C until analysis. Biochemical parameters, which are
glucose, creatinine, urea, aspartate aminotransferase, alanine ami-
notransferase, alkaline phosphatase, total cholesterol, triglycer-
ides, uric acid, albumin, and total proteins were determined by
colorimetric assays with Labtests kits (Minas Gerais, Brazil).
2.5.6. Histopathological analysis
Organ samples from each animal were further processed for
histopathology. Samples were routinely processed and sectioned
at 5 μm, stained by hematoxylin and eosin techniques and
analyzed under a light optical microscope. Vital organs such as
liver, kidneys and lungs were preserved for histopathological
analysis. The organs were ﬁxed in 10% formalin, dehydrated in
ethanol and clariﬁed in xylene. After processing, the tissues were
embedded in parafﬁn and then sectioned to a thickness of 5 μm
using a Hyrax M60 (Carl Zeiss MicroImaging GmbH, Germany).
The sections were stained with hematoxylin and eosin. The
tissues were examined under a microscope in a random order and
blind to the original animal or group. The renal injury was based
on degeneration of Bowman space and glomeruli, degeneration of
proximal and distal tubules, vascular congestion and interstitial
edema. The criteria for liver injury were vacuolization of hepato-
cytes and pyknotic hepatocyte nuclei, number of Kupffer cells and
enlargement of sinusoids. Moreover, the histopathological change
of lungs was based on congestion, edema, inﬂammation and
hemorrhage.
2.6. Data analysis
The data for relative organ weights, hematology and serum
biochemistry were analyzed statistically. Bartlett's test was used
to test for homogeneity of variance between groups. When no
signiﬁcant heterogeneity was detected, one-way analysis of var-
iance (ANOVA) was applied. If parameters were found to demon-
strate signiﬁcant differences between groups, it was followed by
Student–Newman–Keuls multiple comparison. The po0.05 level
was considered as signiﬁcant. GraphPad Prism© version 5.01 for
Windows (GraphPad Software, USA) was used for statistical
analysis. The IC50 was determined from a linear regression curve
relating the percentage of inhibition vs the logarithm of the tested
concentrations and assuming a conﬁdence level of 99% (po0.01)
for the curve obtained. Approximate LD50 was calculated with
geometric means of transition doses (OECD, 2008). For in vitro
assays that do not involve statistical analysis, we used the
mean7SEM of three independent experiments performed in
duplicate.
3. Results
3.1. Quantiﬁcation of total phenolics content
The equation and correlation coefﬁcient of the linearity obtained
for the calibration curve used to quantify total phenols were
y¼0.0689xþ0.0143 and R2¼0.9732, respectively. The mean absor-
bance values revealed a signiﬁcant concentration of phenolic comp-
ounds 199.073.84 mg TAE/g of HEHs.
3.2. Quantiﬁcation of total ﬂavonoid content
The equation and correlation coefﬁcient of the linearity
obtained for the calibration curve used to quantify total were
y¼0.0217x0.0067 and R2¼0.9928, respectively. The mean absor-
bance values revealed a signiﬁcant concentration of ﬂavonoids
144.0170.94 mg RE/g of HEHs.
3.3. HPLC ﬁngerprinting
Analysis by HPLC conﬁrmed the presence of phenolic com-
pounds detected in the preliminary phytochemical analysis and
quantiﬁed spectrophotometrically in HEHs. The chromatographic
proﬁle (ﬁngerprint) obtained by HPLC of HEHs is shown in Fig. 1.
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Naringin (time 24.5 min) was detected in quantities above the
detection of the calibration curve, ellagic acid (time 26.4 min) at a
concentration of 60.802 mg/g totaling 6% of the dry extract and
morin (time 26.7 min) at a concentration of 3.663 mg/g totaling
0.3% of the dry extract.
3.4. Cytotoxicity evaluation
Treatment of CHO-k1 cells with increasing concentrations of
HEHs had no effect on the cell survival (IC504200 μg/mL) up to
72 h. By contrasts, doxorubicin used as a standard was highly
cytotoxic (IC50o1.770.06 mg/ml) to CHO-k1 cells.
3.5. Acute toxicity
In the present study, the male mice proved to be more sensitive
to the toxicological effect of HEHs than the female mice. The male
mice tolerated the dose up to 2000 mg/kg. Doubling the dose
produced clinical signs and at a further increase of 25% in the dose,
death occurred in 80% of the male mice (Table 1). A disparate
picture was obtained for the females. The female mice tolerated the
dose up to 4000 mg/kg and only presented transient diarrhea at
5000 mg/kg. Therefore, whereas no mortality was observed in the
female mice at 5000 mg/kg, therefore the approximate LD50 for the
male was 4472 mg/kg, indicating about 3 fold sensitivity difference
between the genders in this mouse strain, with females being the
more resistant sex in this study.
3.6. Subchronic toxicity
3.6.1. General conditions and behavior
There were no HEHs treatment-related mortalities recorded in
rats after 30 days of oral dosing. None of the animals showed any
obvious morbidity or clinical symptoms of toxicity such as changes
in the skin and fur, eyes, respiratory rate, autonomic (salivation,
perspiration, and piloerection), and central nervous system (ptosis,
drowsiness, abnormal gait, tremor and convulsion) effects through-
out the experimental period.
3.6.2. Body weight, weight gain, food and water consumption, feces
and urine excretion
In this study, all rats in both the control and treated groups
attained signiﬁcant weight gain (46–53%, po0.001) after 30 days
of the experiment compared to their baseline weight. However,
there was no signiﬁcant difference in both the body weight and
accumulated body weight gain in each week throughout the study
period when other treatment groups were compared to the
control. Likewise, there were no signiﬁcant difference in the water
Fig. 1. HPLC chromatogram of the hydroethanolic extract of Helicteres sacarolha. Peak 1: naringin (time 24.5 min); peak 2: ellagic acid (time 26.4 min); peak 3: morin (time
27.1 min).
Table 1
Effects of oral administration of hydroethanolic extract of Helicteres sacarolha
(HEHs) on general behavioral activity in mice of both sexes.
Male
group
Dose
(mg/kg, p.o.)
Behavioral alterations/toxicity signs Death
Vehicle No alteration 0/5
HEHs 500 No alteration 0/5
1000 No alteration 0/5
2000 No alteration 0/5
4000 Moderate reduction in motility, diarrhea 0/5
5000 Reduced motility, passivity, diarrhea,
analgesia
4/5
Female group
Vehicle No alteration 0/5
HEHs 500 No alteration 0/5
1000 No alteration 0/5
2000 No alteration 0/5
4000 No alteration 0/5
5000 Diarrhea 0/5
Table 2
Effect of subchronic oral administration of the hydroethanolic extract of Helicteres
sacarolha (HEHs) on relative weight of the internal organs of rats after 30 days of
treatment.
Organsa Vehicle HEHs (mg/kg)
250 750
Brain 0.6170.01 0.4970.04 0.4970.05
Liver 3.9270.10 4.1570.22 4.6370.22
Spleen 0.2870.10 0.4970.19 1.1270.15nn
Right kidney 0.4670.01 0.4770.00 0.4770.01
Left kidney 0.4770.01 0.4770.00 0.4870.01
Lung 0.6270.03 0.7570.06 0.8370.04n
Heart 0.4270.01 0.4070.01 0.3970.01
Stomach 0.5770.02 0.6370.03 0.6070.01
The values represent mean7S.E.M. for 6 animals/group. One way ANOVA followed
by Student–Newman–Keuls test.
a Relative organ weights in %.
n po0.05 vs vehicle.
nn po0.01 vs vehicle.
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intake and feed consumption, fecal and urine excretions between
the treated groups and the control (data not shown).
3.6.3. Relative organ weights
Administration of HEHs for 30 days did not produce any abnormal
change in the relative body weights, with the exception of the spleen
and the lungs of rats in the 750 mg/kg group, which differed
signiﬁcantly, increasing by about four folds and 33% respectively
when compared with the control group as shown in Table 2.
3.6.4. Biochemical and hematological data
In the biochemical parameters evaluated, all parameters remained
unchanged as non-signiﬁcant variations were observed. As shown in
Table 3, subchronic oral administrationwith HEHs induced signiﬁcant
increases in the leukocyte and basophil counts at 750 mg/kg when
compared to the control. Signiﬁcant decreases were also noticed in
the segmented neutrophil, monocyte and hematochrit counts in the
250 and 750mg/kg groups respectively.
3.6.5. Histopathological examination
Histopathological analysis of the kidney, liver, heart, stomach,
basophil and the brain did not reveal any difference among groups.
In one animal of the 250 mg/kg treated group, mild lung inﬂamma-
tion with perivascular lymphocyte inﬁltration was observed, while
50% of the vehicle control group presented lung hyperplasia (BALT),
a light perivascular inﬁltrate of mononuclear cells. In addition,
bronchiolitis was also observed in the lungs of the vehicle
treated group.
4. Discussion
The search for, and the assessment of in vitro and in vivo models
that are suitable to predict adverse effects in humans exposed
to chemicals represent an important issue in toxicological pharma-
cology (Olson et al., 2000). This is quite true in the case of preclinical
toxicity testing in terms of safety concerns as well as economic gains
in the development of medicines destined for human use (Jordan
et al., 2010). The present study evaluated the potential toxicity
of Helicteres sacarolha, a medicinal plant commonly used in the
treatment of common ailments, particularly in gastric disturbances
(Bieski et al., 2012).
According to the United States National Cancer Institute plant
screening program, a plant extract is generally considered to have
an active cytotoxicity effect if the IC50 value following incubation
between 48 and 72 h is o30 μg/mL (Sufﬁness and Pezzuto, 1990).
Thus, HEHs may be considered non-cytotoxic. We thus procee-
ded to examine the potential toxicity of the extract using in vivo
animal models.
Acute toxicity is usually an initial study performed: to serve as
the basis for classiﬁcation and labeling, to provide initial informa-
tion on the mode of toxic action of a substance, to help arrive at a
dose of a new compound and to help in dose determination in
animal studies (Ukwuani et al., 2012).
Gender discrimination was observed in the acute toxicity test
at higher doses of HEHs (Table 1). There is ample evidence in
scientiﬁc literature that shows gender discrimination with regard
to responses to great variety of drugs (Czerniak, 2001; Sin et al.,
2007; Kadekar et al., 2012). The gender discrimination observed in
the mice may be due to one or more of the several factors already
described. These factors may include gender-based differences in
the hepatic metabolism (which may be due to differences in
expression of sex-speciﬁc cyctochrome P450s), pharmacokinetics
parameters (plasma clearance and volume) and differences in both
phase I and phase II metabolism (Czerniak, 2001).
In order to explain the signiﬁcant difference among groups,
limitrophic values obtained from analysis of control group (higher
and lower values) were employed. In the case where normal range
of control group did not explain the signiﬁcant difference, refer-
ence values published in the literature were utilized (Smith et al.,
2002; Palmeiro et al., 2003).
In subchronic toxicity study, no treatment-related clinical
symptoms or deaths were recorded during the course of the
experiment. Comparison of organ weights between treated and
untreated groups of animals has conventionally been used to
evaluate the toxic effect of the test substance in toxicological
experiments (Michael et al., 2007).
Signiﬁcant differences in the relative organweights of the spleen
and the lungs were observed in the 750 mg/kg treated group with
respect to the control. Rat spleen serves as the major site for the
destruction of red blood cells (Bivin and Crawford, 1979). Thus, the
higher relative weight in the spleen of this experimental group may
be due to increased destruction of the RBCs. However, there was no
corresponding decrease in the RBCs. Thus these were judged to be
of little toxicological signiﬁcance, since no remarkable treatment
related histological alterations in these two organs were observed
(Tasaki et al., 2008; Mu et al., 2011).
Clinical chemistry tests are used in toxicology studies to
generate data that are crucial for evaluating altered organ function
or damage in experimental animals (Smith et al., 2002; Boehm
et al., 2007). In the present subchronic toxicity study of HEHs with
Table 3
Effect of subchronic oral administration of hydroethanolic extract of Helicteres
sacarolha (HEHs) on biochemical and hematological parameters in rats after 30
days of treatment.
Parameters Vehicle HEHs (mg/kg p.o.)
250 750
Biochemical parameters
Glucose (mg/dL) 209.00721.74 238.67722.45 163.33713.30
Urea (mg/dL) 31.3372.17 35.8371.14 37.3372.14
Creatinine (mg/dL) 0.3070.01 0.3170.01 0.2870.01
Aspartate aminotransferase
(U.I)
80.3374.25 87.50717.67 76.33713.29
Alanine aminotransferase
(U.I)
56.0073.90 53.3373.85 48.3371.23
Alkaline phosphatase (U.I) 439.17718.04 412.50737.83 407.50738.74
Total cholesterol (mg/dL) 81.8375.72 80.1775.97 76.1774.25
Triglycerides (mg/dL) 80.33718.04 61.5074.01 79.3375.87
Uric acid (mg/dL) 2.2870.47 3.2570.82 1.0570.18
Total proteins (g/dL) 5.5370.15 5.5870.12 5.3570.09
Albumin (g/dL) 4.1370.09 4.1870.10 4.0570.11
Hematological parameters
Leukocytes (103/mm3) 7.0870.28 6.7270.49 10.0170.67nnn
Segmented neutrophil (%) 22.0670.91 18.1070.64n 19.3771.42
Lymphocytes (%) 74.5270.91 77.5570.61 76.0570.99
Monocytes (%) 0.4970.2 0.5570.03 0.1770.03nnn
Eosinophils (%) 2.6470.39 3.3170.13 3.3070.64
Basophils (%) 0.2970.12 0.4970.20 1.1270.16nn
Erythrocytes (106/mm3) 5.7070.18 5.8270.05 5.4870.09
Hemoglobin (g/dL) 17.3270.51 17.4070.16 16.1770.16n
Hematocrit (%) 51.9471.53 52.2070.47 48.5070.48n
MCV (fL)a 56.4670.41 56.7070.27 55.2270.58
MCH (pg)b 30.3970.26 29.9170.05 29.5370.37
MCHC (g/dL)c 33.82713.80 33.3970.16 33.3870.87
Platelets (103/mm3) 919.20727.53 930.75734.27 912.17733.93
Values represent mean7SEM (n¼6/group). One-way ANOVA followed by Student–
Newman–Keuls test.
a Mean corpuscular volume.
b Mean corpuscular hemoglobin.
c Mean corpuscular hemoglobin concentration.
n po0.05 vs vehicle.
nn po0.01 vs vehicle.
nnn po0.001 vs vehicle.
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daily gavage at 250 and 750 mg/kg/day for 30 days, there were no
alterations in any of the clinical chemistry parameters, suggesting
that there were no alteration or damage of organ function.
Evaluation of hematological parameters represents an important
and relevant risk evaluation as the changes in the hematological
system have a higher predictive value for human toxicity, when the
data are translated from animal studies (Olson et al., 2000). In
addition, hematological analyses provide information about the
hematopoietic system and immunological responses (Igwebuike
and Obidike, 2007).
The hematological proﬁle of treated rats showed no signiﬁcant
difference with control group, except in few cases that occurred in
a sporadic manner. The leukocytes count was signiﬁcantly elevated
in the higher dose group while the neutrophil level was lesser in the
lower dose group. However, these values were considered normal
since they are within the reference values (Melo et al., 2013). The
differences found in the hemoglobin and hematocrit values are
within the normal range relative to the limitrophic values of the
control group (14.9–18.5 g/dL and 44.70–55.40%, respectively).
Leukocyte differential count showed signiﬁcant difference in the
percentage of monocytes and the basophils. These changes were
only observed in the higher dose, but were not accompanied by any
clinical or histopathological changes. It is therefore unlikely to be of
toxicological relevance since clinical conditions (monocytosis and
basophilia) were not manifested in any of the rats. Additionally, the
levels of eosinophils were maintained in the physiological range,
indicating the absence of allergic process to HEHs.
Histopathological analysis revealed the presence of mild peri-
vascular mononuclear cell inﬁltrates and bronchiolitis in the lungs
of only one animal in the lower dose group, suggesting a chronic
inﬂammation process. These alterations are not treatment related,
since similar observations were noted in the control group. This
type of alterations are not uncommon in rats subjected to this kind
of assay (Tasaki et al., 2008; Beserra et al., 2010). Although no
histopathological changes and clinical constituents were observed
in the present subchronic toxicity study, caution should be taken
in using the extract at high doses.
UV-Spectrophotometric quantiﬁcation of HEHs demonstrated
signiﬁcant amount of the ﬂavonoids and the phenolics, while HPLC
conﬁrmed the presence of and quantiﬁed selected phenolics,
precisely, ellagic acid, morin and naringin. Ellagic acid is known
for its wide array of biological and pharmacological properties. It
has antioxidant and free radical scavenging effects, among others
(Beserra et al., 2011; Rosillo et al., 2012). It is an approved food
additive in Japan, due to its antioxidant property (Tasaki et al.,
2008). A number of studies have addressed the potential toxicity
of ellagic acid, and has been shown to be non-toxic even at high
doses (Tasaki et al., 2008; Beserra et al., 2010). This may have
contributed substantially to the non-toxic effect of HEHs observed
in the present study, as ellagic acid is 6% of the dry extract. A study
by Li et al. (2013) demonstrated that naringin at a single dose of
16 g/kg and 13 weeks oral treatment at up to 1250 mg/kg had no
adverse effects on Sprague-Dawley rats. In addition, naringin is
known to protect against oxidative damage, cancer, inﬂammation,
gastric ulcer and neurotoxicity, among others, in both in vitro and
in vivo assays (Borrelli and Izzo, 2000; Li et al., 2013). Morin, also
a phenolic compound detected in HEHs has received atten-
tion recently due to its desirable pharmacological properties
(Kim et al., 2004; Bellik et al., 2012; Costa et al., 2012). A 13-
week toxicological study on morin (Cho et al., 2006) demonstrated
signiﬁcant alterations in some biochemical parameters at different
doses in male and female rats, including increases in the relative
liver and kidney weights. In the same study, no observed adverse
effect level (NOAEL) in f344 rats fed morin supplemented feed was
299 and 356 mg/kg b.w./day for males and females, respectively. In
the present study, the equivalent doses of morin were 0.75 and
2.25 mg/kg at the doses of HEHs of 250 and 750 mg/kg, respec-
tively. Therefore, it is unlikely that morin will cause any toxic effect
in the present study.
The NOAEL of HEHs is therefore calculated to be above 750 mg/kg
b.w. The human equivalent dose (HED) of 750 mg/kg in the rats using
body surface area (Reagan-Shaw et al., 2007) is 121.62 mg/kg. In
popular medicine, an adult takes 2 cups (300 ml/day) of the leaves
infusion of Helicteres sacarolha for 20–30 days. This is equivalent to
360 mg of the extract, translating to an intake of 5.14 mg/kg per day
for an adult of 70 kg weight, considering that an infusion of 10 g in
1 L of water rendered 1.2 g (preliminary data). Thus, the HED is 23
times more than the approximate dose used by the population. The
maximum dose tested in the acute toxicity study that caused no
behavioral alteration in mice of both sexes was 2000 mg/kg, while
the maximum dose in the subchronic study realized in rats was
750 mg/kg. The HED in both cases was, respectively, about 32 times
and 23 times more than the dose ingested by humans, thus
indicating high safety margin of HEHs in the form being utilized.
5. Conclusion
In summary, based on the toxicological parameters evaluated in
this current study, we conclude that HEHs have a broad safety
margin for therapeutic use. Thus, the present study indicates that
HEHs is safe in rats at a NOAEL of up to an oral dose of 750 mg/kg
b.w./day for 30 days. The results presented here will be of use in
future development of Helicteres sacarolha as an alternative in the
treatment of common ailments, especially those indicated for
Helicteres sacarolha by the Community.
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